Clinical Trial Update: A Study of TQ05105 Tablets in Subjects With Glucocorticoid-Refractory Acute Graft-Versus-Host Disease (aGVHD) [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/Phase 2 study of TQ05105 tablets for glucocorticoid-refractory acute graft-versus-host disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease

Drugs mentioned

• TQ05105

Snippet

Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Conditions: Glucocorticoid-Refractory aGVHD | Phase 1, Phase 2 | Status: COMPLETED